Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer	Adnexal Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, drug allergy, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorder	Recruiting	Not applicable	2026-10-07		NCT06977594

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Korea Health Industry Development Institute	11
Seoul National University Boramae Hospital	12
Seoul National University Bundang Hospital	114
Seoul National University Hospital	277

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Seoul National University Hospital	Seoul	South Korea	393